Mid Atlantic Bio Angels (MABA) is a NY-based life science angel investor group, formed in 2012, that invests exclusively in life science companies, with no geographic limitations.
Individual Accredited Members
MDs, many of whom are practicing physicians
Current and past pharmaceutical, biotech or medical device company execs & employees
Current and past C-level and life science company founders
Corporate and IP attorneys
PE, VC, hedge fund founders & execs
Various medical specialties
Finance (several MBAs)
Several pharmaceutical and device companies have also joined MABA as members
Investments typically include:
MABA members-only Pools
MABA’s co-investment Sidecar Fund – for non-MABA members
Between $250,000 and $1 million in initial round
Participation in follow-on rounds
Sign up to receive periodic emails from MABA
Mid Atlantic Bio Angels group (MABA), is an angel investor group focused exclusively on new and emerging life science companies.
Membership in MABA is by invitation only, and is extended to active, accredited investors (life science angels) who wish to make investments in life science companies, as well as institutional investors and life science company venture arms wishing to invest alongside the angels.